Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 6 EP applications Johann Then has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12790551

CRYSTALLINE SALTS OF R)-3-[6-AMINO-PYRIDIN-3-YL]-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL)-PROPIONIC ACID

IPC classification:
A61K 31/4439, C07D 401/06, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12791162

SODIUM SALT OF (R)-3-[6-AMINO-PYRIDIN-3-YL]-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL)-PROPIONIC ACID

IPC classification:
A61K 31/4439, C07D 401/06, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12788550

SALT OF (R)-3-(6-AMINO-PYRIDIN-3-YL)-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL) ETHYL PROPIONATE

IPC classification:
A61K 31/4439, C07D 401/06, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13305762

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

IPC classification:
C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP13306436

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

IPC classification:
A61K 39/00, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11779661

PROCESS FOR THE PREPARATION OF 3-(6-AMINO-PYRIDIN-3YL)-2-ACRYLIC ACID DERIVATIVES

IPC classification:
C07D 233/84, C07D 233/64
Applicant:
Sanofi
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature